Carey LA - Search Results

1

Triple negative breast cancer: Pitfalls and progress.

Zagami P, Carey LA. Zagami P, et al. Among authors: carey la. NPJ Breast Cancer. 2022 Aug 20;8(1):95. doi: 10.1038/s41523-022-00468-0. NPJ Breast Cancer. 2022. PMID: 35987766 Free PMC article. Review.

2

Central nervous system metastases in women after multimodality therapy for high risk breast cancer.

Carey LA, Ewend MG, Metzger R, Sawyer L, Dees EC, Sartor CI, Moore DT, Graham ML. Carey LA, et al. Breast Cancer Res Treat. 2004 Dec;88(3):273-80. doi: 10.1007/s10549-004-0999-3. Breast Cancer Res Treat. 2004. PMID: 15609130

3

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.

Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM. Carey LA, et al. Clin Cancer Res. 2007 Apr 15;13(8):2329-34. doi: 10.1158/1078-0432.CCR-06-1109. Clin Cancer Res. 2007. PMID: 17438091

4

Understanding and treating triple-negative breast cancer.

Anders C, Carey LA. Anders C, et al. Among authors: carey la. Oncology (Williston Park). 2008 Oct;22(11):1233-9; discussion 1239-40, 1243. Oncology (Williston Park). 2008. PMID: 18980022 Free PMC article. Review.

5

What is triple-negative breast cancer?

Irvin WJ Jr, Carey LA. Irvin WJ Jr, et al. Among authors: carey la. Eur J Cancer. 2008 Dec;44(18):2799-805. doi: 10.1016/j.ejca.2008.09.034. Epub 2008 Nov 12. Eur J Cancer. 2008. PMID: 19008097 Review.

6

Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer.

Anders CK, Carey LA. Anders CK, et al. Among authors: carey la. Clin Breast Cancer. 2009 Jun;9 Suppl 2(Suppl 2):S73-81. doi: 10.3816/CBC.2009.s.008. Clin Breast Cancer. 2009. PMID: 19596646 Free PMC article. Review.

7

Through a glass darkly: advances in understanding breast cancer biology, 2000-2010.

Carey LA. Carey LA. Clin Breast Cancer. 2010 Jun;10(3):188-95. doi: 10.3816/CBC.2010.n.026. Clin Breast Cancer. 2010. PMID: 20497917 Review.

8

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer.

Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA. Anders CK, et al. Among authors: carey la. Clin Cancer Res. 2010 Oct 1;16(19):4702-10. doi: 10.1158/1078-0432.CCR-10-0939. Epub 2010 Sep 21. Clin Cancer Res. 2010. PMID: 20858840 Free PMC article. Review.

9

Directed therapy of subtypes of triple-negative breast cancer.

Carey LA. Carey LA. Oncologist. 2010;15 Suppl 5:49-56. doi: 10.1634/theoncologist.2010-S5-49. Oncologist. 2010. PMID: 21138955 Free article.

10

Phase II study of bortezomib and pegylated liposomal doxorubicin in the treatment of metastatic breast cancer.

Irvin WJ Jr, Orlowski RZ, Chiu WK, Carey LA, Collichio FA, Bernard PS, Stijleman IJ, Perou C, Ivanova A, Dees EC. Irvin WJ Jr, et al. Among authors: carey la. Clin Breast Cancer. 2010 Dec 1;10(6):465-70. doi: 10.3816/CBC.2010.n.061. Clin Breast Cancer. 2010. PMID: 21147690 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page